ArticleInternational journal of clinical and experimental medicine2015

Effectiveness and risk associated with infliximab alone and in combination with immunosuppressors for Crohn's disease: a systematic review and meta-analysis.

Zhe Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.